Ichosia, a startup developed by sophomore microbiology major Lucas Vining-Recklitis and three other students, is developing a genetically engineered red blood cell product for blood transfusions treatments.
Biology Student Working on a Potential Replacement for Blood in the Transfusion System
May 1, 2020
